However, the triple combination of PIC + RT + anti-CTLA-4 significantly suppressed tumor growth in this model and improved overall survival compared to RT + anti-CTLA-4 treatment (Fig. 6e–g). This evidence concerns the gene CTLA4 and neoplasm.